More about PE-22-28 (8mg)
PE-22-28 (8mg) is a synthetic peptide fragment derived from the larger spadin peptide sequence and is studied in laboratory environments for its interaction with neurochemical signaling pathways. Researchers investigate PE-22-28 for its potential role in modulating receptor activity and influencing intracellular signaling mechanisms associated with neural communication. This compound is supplied strictly for controlled laboratory research applications.
Peptide fragments like PE-22-28 are of particular interest in neuroscience due to their targeted interaction with specific receptors and signaling pathways. These compounds are often evaluated in experimental models to better understand how peptide-based molecules influence neurotransmission and cellular signaling dynamics. Foundational research on peptide signaling pathways can be reviewed through
NCBI’s overview of neurotransmitter systems.
PE-22-28 (8mg) – Research Specifications:
| Compound | PE-22-28 |
| Quantity | 8mg per vial |
| Compound Type | Synthetic peptide fragment studied for neurochemical signaling |
| Purity / Identity | Research-grade; refer to Certificate of Analysis (COA) for lot-specific analytical verification |
| Appearance | Lyophilized peptide powder |
| Storage Conditions | Store sealed in a cool, dry environment protected from heat, light, and moisture |
| Research Use Only | Supplied exclusively for laboratory research use. Not for human consumption. |
What Is PE-22-28? Research Background
PE-22-28 is a shortened peptide sequence derived from spadin, which itself originates from the sortilin propeptide. Spadin-related peptides have been studied for their interaction with potassium channels and receptor-mediated signaling pathways in neural systems. By isolating the PE-22-28 fragment, researchers can evaluate specific functional domains of the peptide in controlled experimental settings.
One area of interest in PE-22-28 research involves its interaction with TREK-1 potassium channels, which play a role in regulating neuronal excitability and cellular signaling. Research into these ion channels is documented in sources such as
Frontiers in Pharmacology, providing context for how peptide fragments may influence ion channel behavior.
By studying targeted fragments like PE-22-28, researchers can isolate specific mechanisms within broader peptide signaling systems. This allows for more precise evaluation of receptor interactions, ion channel modulation, and downstream signaling effects within neural environments.
Important Research Notice: Nordsci research materials are supported by lot-specific analytical documentation. Certificates of Analysis are available for laboratories requiring verification of compound identity and analytical quality standards.
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR CONDITION.
PE-22-28 – Key Research Applications
1. Ion Channel and TREK-1 Research
TREK-1 potassium channels are involved in regulating neuronal excitability and membrane potential. PE-22-28 is studied for its potential interaction with these channels in controlled laboratory models.
2. Neurotransmitter and Signaling Pathway Studies
Neurotransmitter systems rely on coordinated signaling between receptors, ion channels, and intracellular pathways. Researchers may investigate how PE-22-28 influences these systems within neural communication networks.
3. Peptide–Receptor Interaction Research
Peptide fragments can bind to receptors and influence downstream signaling cascades. Broader receptor signaling mechanisms are outlined in research such as
Nature Reviews Drug Discovery, which provides insight into peptide-receptor dynamics.
4. Cellular Communication and Neural Network Studies
Cellular communication within neural networks depends on complex signaling interactions. Laboratory research may evaluate how peptide fragments like PE-22-28 contribute to these processes.
Handling and Research Use Considerations
PE-22-28 (8mg) should be handled according to standard laboratory protocols for peptide compounds. Proper storage conditions, environmental controls, and careful experimental design are essential for maintaining compound integrity and ensuring reproducible research results.
Protocol Design Considerations: Research outcomes may vary based on receptor expression, ion channel behavior, environmental variables, and peptide stability. Controlled methodologies are critical for accurate data interpretation.
Note: The information above is provided strictly for laboratory research reference purposes. All experiments should be conducted by qualified personnel within appropriate laboratory environments.
PE-22-28 (8mg) – Certificate of Analysis (COA)
Each lot of PE-22-28 supplied by Nordsci Peptides includes a Certificate of Analysis confirming compound identity and analytical purity verification. These reports support laboratory documentation and traceability requirements within research workflows.
Where to Buy PE-22-28 for Research
Laboratories sourcing peptide fragments require consistent quality, transparent verification, and reliable production standards. Nordsci Peptides supplies research-grade PE-22-28 designed to meet the analytical and operational needs of modern research environments.
IMPORTANT: PE-22-28 (8mg) is supplied exclusively for laboratory research use. It is not approved for human consumption or therapeutic use. Researchers are responsible for ensuring compliance with all applicable regulatory and institutional guidelines.